Related Experiment Video
Updated: Apr 25, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer
Xiao-Jie Bian1, Gui-Ming Zhang, Cheng-Yuan Gu
1Department of Urology, Fudan University Shanghai Cancer Center, No. 270, Dong'an Road, Shanghai, 200032, China.
Abstract:
Dicer and Argonaute2 (Ago2) are critical components responsible not only for RNA interference but also for microRNA synthesis. The present study investigated the roles of Dicer and Ago2 in prostate cancer (Pca). First, the expression levels of Dicer and Ago2 in Pca tissues were determined by immunohistochemistry (IHC) and compared with pathological features. Next, RNA interference was used to down-regulate the expression levels of Dicer and Ago2 in the Pca cell lines LNCaP, PC-3, and DU145, and effects on proliferation, apoptosis, and cell cycle were detected using the CCK-8 assay and flow cytometry, respectively. We found that Dicer and Ago2 expression levels in Pca tissues were higher than those in adjacent benign tissues and correlated with lower Gleason patterns, with the exception of Dicer expression in localized Pca. In vitro, silencing Dicer or Ago2 inhibited cell proliferation and induced apoptosis in LNCaP, PC-3, and DU145, as well as arrested the cell cycle at the G2/M phase in androgen-dependent LNCaP, or at S phase in the androgen-independent PC-3 and DU145. Altogether these findings suggest that Dicer and Ago2 play important roles in proliferation, apoptosis, and the cell cycle in Pca and might serve as both promising biomarkers for Pca progression and potential therapeutic targets.
Insights
Dicer and Argonaute2 (Ago2) are crucial for microRNA synthesis and RNA interference. Their elevated expression in prostate cancer (Pca) correlates with disease progression, suggesting they are potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Dicer and Argonaute2 (Ago2) are key enzymes in microRNA biogenesis and RNA interference pathways.
- MicroRNAs play significant roles in regulating gene expression and are implicated in various cancers, including prostate cancer (Pca).
Purpose of the Study:
- To investigate the expression levels and functional roles of Dicer and Ago2 in prostate cancer.
- To evaluate the potential of Dicer and Ago2 as biomarkers for Pca progression and as therapeutic targets.
Main Methods:
- Immunohistochemistry (IHC) was used to assess Dicer and Ago2 expression in Pca tissues and compare with pathological features.
- RNA interference (RNAi) was employed to down-regulate Dicer and Ago2 in Pca cell lines (LNCaP, PC-3, DU145).
- Cell proliferation, apoptosis, and cell cycle distribution were analyzed using CCK-8 assays and flow cytometry.
Main Results:
- Dicer and Ago2 expression levels were significantly higher in Pca tissues compared to adjacent benign tissues.
- Higher expression of Dicer and Ago2 correlated with lower Gleason patterns in Pca, indicating a role in disease progression.
- Silencing Dicer or Ago2 inhibited proliferation, induced apoptosis, and caused cell cycle arrest (G2/M or S phase) in Pca cell lines.
Conclusions:
- Dicer and Ago2 are critically involved in regulating proliferation, apoptosis, and cell cycle progression in prostate cancer.
- These proteins represent promising biomarkers for monitoring Pca progression.
- Dicer and Ago2 emerge as potential therapeutic targets for prostate cancer treatment.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Experimental RNAi
Inhibition of Cdk Activity
Inhibition of CDK Activity
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

